Abstract
A female subject dependent on long-term total parenteral nutrition developed an aversion and noncompliance to a prescribed weekly lipid infusion designed to meet essential fatty acid (EFA) requirements. Fatty acids (FA) in the subject's plasma and isolated peripheral blood neurophils were analyzed in search of biochemical evidence of EFA deficiency. Neutrophil 5-lipoxygenase metabolism was examined to assess the possible effects of EFA deficiency on neutrophil eicosanoid metabolism. EFA deficiency was confirmed by marked depletion of linoleic acid (18∶2n−6) and accumulation of eicosatrienoic acid (ETrA; 20∶3n−9) in plasma and neutrophil phospholipids. In the neutrophils, ETrA comprised 5.2% of phospholipid FA (normal reference values <0.1%), and arachidonic acid (AA; 20∶4n−6) comprised 8.6% of phospholipid FA (normal reference range 10–16%). When stimulated by A23187in vitro on three separate occasions, the subject's neutrophils displayed impaired synthesis of leukotriene B4 (LTB4), but produced normal amounts of 5-hydroxyeicosatetraenoic acid andall-trans isomers of LTB4 formed nonenzymatically from leukotriene A4 (LTA4). This pattern of synthesis suggested inhibition of LTA hydrolase and was also seen in neutrophils from healthy subjects by addition of exogenous ETrAin vitro. Comparative studies of the effects of ETrA and eico-sapentaenoic acid (20∶5n−3) on neutrophilsin vitro suggested that ETrA is the more potent inhibitor. Accumulation of ETrA, rather than depletion of AA, appears principally responsible for the observed impairment of neutrophil LTB4 synthesis seen in this EFA-deficient subject.
Similar content being viewed by others
Abbreviations
- AA:
-
arachidonic acid (20∶4n−6)
- EFA:
-
essential fatty acids
- EPA:
-
eicosapentaenoic acid
- ETrA:
-
n−9 eicosatrienoic acid (20∶3n−9)
- FA:
-
fatty acids(s)
- HPLC:
-
high-performance liquid chromatography
- LA:
-
linoleic acide (18∶2n−6)
- LTA:
-
leukotriene A
- LTB4 :
-
leukotriene B4
- 5-HETE:
-
5-hydroxyeicosatetraenoic acid
References
Holman, R.T. (1986)J. Am. Coll.Nutr. 5, 183–211.
Collins, D., Sinclair, A.J., Royle, J.P., Coast, D.A., Maynard, A.T., and Leonard, R. (1971)Nutr. Metab. 13, 150–167.
Bonta, I.L., Chrispijn, H., Noordhoek, J., and Vincent, J.E. (1974)Prostaglandins 5, 495–503.
Bonta, I.L., Parnham, M.J., and Adolfs, M.J. (1977)Prostaglandins 14, 295–307.
Denko, C.W. (1976)Agents Actions 6, 636–641.
Hurd, E.R., Johnston, J.M., Okita, J.R., MacDonald, P.C., Ziff, M., and Gilliam, J.N. (1981)J. Clin. Invest. 67, 476–485.
Schreiner, G.F., Rovin, B., and Lefkowith, J.B. (1989)J. Immunol. 43, 3192–3199.
Ferreira, S.H., Moncada, S., and Vane, J.R. (1973)Br. J. Pharmacol. 49, 86–97.
Williams, T.J., and Morley, J. (1973)Nature 246, 215–217.
Moncada, S., Ferreira, S.H., and Vane, J.R. (1973)Nature 246, 217–219.
Goodwin, J.S., and Webb, D.R. (1980)Clin. Immun. Immunopath. 15, 106–122.
Samuelsson, B. (1983)Science 220, 568–575.
Dinarello, C.A., Bishai, I., Rosenwasser, L.J., and Coceani, F. (1984)Int. J. Immunopharmacol. 6, 43–50.
Rola-Pleszczynski, M., and Lemaire, I. (1985)J. Immunol. 135, 3958–3961.
Rola-Pleszczynski, M., and Chavaillaz, P.A., and Lemaire, I. (1986)Prostagl. Leukotr. Med. 23, 207–210.
Johnson, H.M., and Torres, B.A. (1984)J. Immunol. 132, 413–416.
Payan, D.G., Missirian-Bastian, A., and Goetzl, E.J. (1984)Proc. Natl. Acad. Sci. USA 81, 3501–3505.
Gualde, N., Atluru, D., and Goodwin, J.S. (1985)J. Immunol. 134, 1125–1129.
Lefkowith, J.B. (1988)J. Immunol. 140, 228–233.
Lefkowith, J.B., Morrison, A., Lee, V., and Rogers, M. (1990)J. Immunol. 145, 1523–1529.
McMurchie, E.J., Rinaldi, J.A., Burnard, S.L., Patten, G.S., Neumann, M.A., McIntosh, G.H., Abbey, M.A. and Gibson, R.A. (1990)Biochim. Biophys. Acta 1045, 164–173.
McColl, S.R., Betts, W.H., Murphy, G.A., and Cleland, L.G. (1986)J. Chromatogr. Biomed. Applic. 378, 444–449.
James, M.J., Cleland, L.G., Gibson, R.A., and Hawkes, J.S. (1991)J. Nutr. 121, 631–637.
Jakschik, B.A., Morrison, A.R., and Sprecher, H. (1983)J. Biol. Chem. 258, 12797–12800.
Stenson, W.F., Prescott, S.M., and Sprecher, H. (1984)J. Biol. Chem. 259, 11784–11789.
Evans, J.F., Nathaniel, D.J., Zamboni, R.J., and Ford-Hutchinson, A.W. (1985)J. Biol. Chem. 260, 10966–10970.
Cleland, L.G., French, J.K., Betts, W.H., Murphy, G.A., and Elliott, M.J. (1988)J. Rheumatol. 15, 1471–1475.
Sperling, R.I., Weinblatt, M., Robin, J.L., Ravalese, J., Hoover, R.L., House, F., Coblyn, J.S., Fraser, P.A., Spur, B.W., Robinson, D.R., Lewis, R.A., and Austen, K.F. (1987)Arthritis Rheum, 30, 988–997.
Prescott, S.M. (1984)J. Biol. Chem. 259, 7615–7621.
Terano, T., Salmon, J.A., and Moncada, S. (1986)Biochem. Pharmacol. 35, 779–785.
Goldman, D.W., Pickett, W.C., and Goetzl, E.J. (1983)Biochem. Biophys. Res. Commun. 117, 282–288.
Lee, T.H., Tariq, S., Crea, A.E.G., Peters, W., Arm, J.P., Horton, C.E., Walport, M.J., and Spur, B.W., (1988)Clin. Sci. 74, 467–475.
Kremer, J.M., Jubiz, W., Michalek, A., Rynes, R.I., Bartholomew, L.E., Bigaouette, J., Timchalk, M., Beeler, D., and Lininger, L. (1987)Ann. Intern. Med. 106, 497–503.
Kremer, J.M., Lawrence, D.A., Jubiz, W., DiGiacomo, R., Rynes, R., Bartholomew, L.E., and Sherman, M. (1990)Arthritis Rheum. 33, 810–820.
Prickett, J.D., Trentham, D.E., and Robinson, D.R. (1984)J. Immunol. 132, 725–729.
McColl, S.R., Cleland, L.G., Whitehouse, M.W., and Vernon-Roberts, B. (1987)J. Rheumatol. 14, 197–201.
Kelley, V.E., Ferretti, A., Izui, S., and Strom, T.B. (1985)J. Immunol. 134, 1914–1919.
Bittiner, S.B., Tucker, W.F., Cartwright, I., and Bleehen, S.S. (1988)Lancet. 1, 378–380.
Bjorneboe, A., Smith, A.K., Bjorneboe, G.E., Thune, P.O., and Drevon, C.A. (1988)Br. J. Dermatol. 118, 77–83.
Cleland, L.G., Gibson, R.A., Hawkes, J.S., and James, M.J. (1990)Lipids. 25, 559–564.
Adam, O., Wolfram, G., and Zollner, N. (1986)J. Lipid Res. 27, 421–426.
Lee, T.H., Hoover, R.L., Williams, J.D., Sperling, R.I., Ravalese, J., Spur, B.W., Robinson, D.R., Corey, E.J., Lewis, R.A., and Austen, K.F. (1985)N. Engl. J. Med. 312, 1217–1224.
Endres, S., Ghorbani, R., Kelley, V.E., Georgilis, K., Lonnemann, G., van der Meer, J.W.M., Cannon, J.G., Rogers, T.S., Klempner, M.S., Weber, P.C., Schaefer, E.J., Wolff, S.M., and Dinarello, C.A. (1989)N. Engl. J. Med. 320, 265–271.
Cleland, L.G., James, M.J., Neumann, M.A., D'Angelo, M., and Gibson, R.A. (1992)Am. J. Clin. Nutr. 55, 395–399.
Yazawa, K., Araki, K., Okazaki, N., Watanabe, K., Ishikawa, C., Inoue, A., Numao, N., and Kondo, K. (1988)J. Biochem. (Tokyo) 103, 5–7.
Neuville, D. (1990)C. Soc. Biol. (Paris) 184, 135–139.
James, M.J., Cleland, L.G., and Gibson, R.A. (1992)Biochem. Pharmacol. 43, 695–700.
Author information
Authors and Affiliations
About this article
Cite this article
Cleland, L.G., James, M.J., Proudman, S.M. et al. Inhibition of human neutrophil leukotriene B4 synthesis in essential fatty acid deficiency: Role of leukotriene a hydrolase. Lipids 29, 151–155 (1994). https://doi.org/10.1007/BF02536722
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536722